FDA advises blood pressure patients to take tainted medication amidst shortage
Apr 5, 2019
After having a shortage of clean manufactured medications, the FDA encourages blood pressure patients to use tainted pills available in the market while a new batch is produced. Angiotensin II receptors blockers were taken off the market due to impurities found during the manufacturing process of the pills. Medical components like Valsartan, losartan, and irbesartan were tainted by nitrosamines which are a risk factor for cancer that can be mistakenly introduced in the pills during the fabrication process. This event has made the agency more flexible with the safety guidelines for alternative medication. Pharmacies have been able to track down the affected batches and were able to warn the patients.